Alterity Therapeutics
ATHE
24 hedge funds and large institutions have $1.29M invested in Alterity Therapeutics in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 8 closing their positions.
7% less call options, than puts
Call options by funds: $141K | Put options by funds: $152K
8% less funds holding
Funds holding: 26 → 24 (-2)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
27% less capital invested
Capital invested by funds: $1.75M → $1.29M (-$466K)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$258K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$147K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$54.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$38.2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$32.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$200K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$192K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$175K |
| 4 |
Morgan Stanley
New York
|
-$97.4K |
| 5 |
Goldman Sachs
New York
|
-$67K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GA
26
Geneva Advisors
Chicago,
Illinois
| – | -$24K | -184 | Closed |
|
27
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$7.24K | -67 | -91% |
|
|
WCM
28
Westend Capital Management
Sausalito,
California
| – | -$5K | -41 | Closed |
|
29
Ameriprise
Minneapolis,
Minnesota
| – | -$4K | -32 | Closed |
|
30
Citigroup
New York
| – | -$3.03K | -28 | -97% |
|
ATHE Hedge Fund Activity: Q4 2014 in Review
24 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2014, worth a combined $1.29M — down 27% from $1.75M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ATHE and 7 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 3 added.
The largest buyer was Virtu KCG Holdings, adding an estimated $258K. The largest seller was Jane Street, exiting entirely with an estimated $200K sold.
- 24 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2014, down from 26 in Q3 2014.
- Funds reported $1.29M of Alterity Therapeutics stock for Q4 2014, down 27% quarter-over-quarter.
- 7 funds opened new Alterity Therapeutics positions in Q4 2014 and 8 closed out, a net change of -1 holder.
- The largest Alterity Therapeutics buyer in Q4 2014 was Virtu KCG Holdings, an estimated $258K added.
- The largest Alterity Therapeutics seller in Q4 2014 was Jane Street, an estimated $200K sold.
Based on aggregated 13F filings for Q4 2014.